WallStSmart

Lazard Ltd (LAZ)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 72763% more annual revenue ($2.33T vs $3.20B). NMR leads profitability with a 17.3% profit margin vs 7.1%. NMR appears more attractively valued with a PEG of 0.82. NMR earns a higher WallStSmart Score of 84/100 (A-).

LAZ

Buy

53

out of 100

Grade: C-

Growth: 3.3Profit: 6.0Value: 6.3Quality: 5.5
Piotroski: 3/9Altman Z: 2.05

NMR

Exceptional Buy

84

out of 100

Grade: A-

Growth: 10.0Profit: 7.0Value: 7.0Quality: 3.0
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LAZ2 strengths · Avg: 9.0/10
Return on EquityProfitability
31.5%10/10

Every $100 of equity generates 31 in profit

PEG RatioValuation
1.008/10

Growing faster than its price suggests

NMR6 strengths · Avg: 9.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Operating MarginProfitability
30.8%10/10

Strong operational efficiency at 30.8%

Revenue GrowthGrowth
31.2%10/10

Revenue surging 31.2% year-over-year

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.8x8/10

Attractively priced relative to earnings

EPS GrowthGrowth
42.0%8/10

Earnings expanding 42.0% YoY

Areas to Watch

LAZ4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.1%4/10

0.1% revenue growth

Profit MarginProfitability
7.1%3/10

7.1% margin — thin

Operating MarginProfitability
4.8%3/10

Operating margin of 4.8%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

NMR2 concerns · Avg: 1.5/10
Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
9.181/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : LAZ

The strongest argument for LAZ centers on Return on Equity, PEG Ratio. PEG of 1.00 suggests the stock is reasonably priced for its growth.

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, Operating Margin, Revenue Growth. Profitability is solid with margins at 17.3% and operating margin at 30.8%. Revenue growth of 31.2% demonstrates continued momentum.

Bear Case : LAZ

The primary concerns for LAZ are Revenue Growth, Profit Margin, Operating Margin. Debt-to-equity of 2.35 is elevated, increasing financial risk.

Bear Case : NMR

The primary concerns for NMR are Altman Z-Score, Debt/Equity. Debt-to-equity of 9.18 is elevated, increasing financial risk.

Key Dynamics to Monitor

LAZ profiles as a value stock while NMR is a growth play — different risk/reward profiles.

LAZ carries more volatility with a beta of 1.42 — expect wider price swings.

NMR is growing revenue faster at 31.2% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (84/100 vs 53/100), backed by strong 17.3% margins and 31.2% revenue growth. Both earn "Exceptional Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lazard Ltd

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Lazard Ltd, is a financial advisory and asset management firm in North America, Europe, Asia, Australia, and Central and South America. The company is headquartered in Hamilton, Bermuda.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?